Clearview Wealth Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $714K | Sell |
3,847
-9
| -0.2% | -$1.67K | 0.5% | 43 |
|
|
2025
Q1 | $808K | Sell |
3,856
-128
| -3% | -$26.8K | 0.6% | 34 |
|
|
2024
Q4 | $708K | Sell |
3,984
-34
| -0.8% | -$6.04K | 0.54% | 40 |
|
|
2024
Q3 | $794K | Sell |
4,018
-106
| -3% | -$20.9K | 0.61% | 37 |
|
|
2024
Q2 | $707K | Sell |
4,124
-177
| -4% | -$30.4K | 0.62% | 36 |
|
|
2024
Q1 | $783K | Sell |
4,301
-129
| -3% | -$23.5K | 0.8% | 30 |
|
|
2023
Q4 | $687K | Buy |
4,430
+18
| +0.4% | +$2.79K | 0.8% | 44 |
|
|
2023
Q3 | $658K | Sell |
4,412
-351
| -7% | -$52.3K | 0.81% | 46 |
|
|
2023
Q2 | $642K | Sell |
4,763
-54
| -1% | -$7.28K | 0.65% | 45 |
|
|
2023
Q1 | $768K | Sell |
4,817
-1,833
| -28% | -$292K | 0.78% | 32 |
|
|
2022
Q4 | $1.07M | Buy |
6,650
+27
| +0.4% | +$4.36K | 0.83% | 26 |
|
|
2022
Q3 | $889K | Buy |
6,623
+204
| +3% | +$27.4K | 0.7% | 24 |
|
|
2022
Q2 | $983K | Buy |
6,419
+144
| +2% | +$22.1K | 0.74% | 23 |
|
|
2022
Q1 | $1.02M | Sell |
6,275
-148
| -2% | -$24K | 0.67% | 26 |
|
|
2021
Q4 | $870K | Buy |
6,423
+293
| +5% | +$39.7K | 0.53% | 44 |
|
|
2021
Q3 | $661K | Sell |
6,130
-353
| -5% | -$38.1K | 0.42% | 53 |
|
|
2021
Q2 | $730K | Buy |
6,483
+381
| +6% | +$42.9K | 0.45% | 49 |
|
|
2021
Q1 | $660K | Buy |
6,102
+608
| +11% | +$65.8K | 0.43% | 53 |
|
|
2020
Q4 | $589K | Buy |
+5,494
| New | +$589K | 0.4% | 56 |
|